Generation of an induced pluripotent stem cells line, CSSi014-A 9407, carrying the variant c.479C>T in the human iduronate 2-sulfatase (hIDS) gene

Stem Cell Res. 2022 Aug:63:102846. doi: 10.1016/j.scr.2022.102846. Epub 2022 Jun 21.

Abstract

Mucopolysaccharidosis type II (Hunter Syndrome) is a rare X-linked inherited lysosomal storage disorder presenting a wide genetic heterogeneity. It is due to pathogenic variants in the IDS gene, causing the deficit of the lysosomal hydrolase iduronate 2-sulfatase, degrading the glycosaminoglycans (GAGs) heparan- and dermatan-sulfate. Based on the presence/absence of neurocognitive signs, commonly two forms are recognized, the severe and the attenuate ones. Here we describe a line of induced pluripotent stem cells, generated from dermal fibroblasts, carrying the mutation c.479C>T, and obtained from a patient showing an attenuated phenotype. The line will be useful to study the disease neuropathogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Glycosaminoglycans
  • Humans
  • Iduronate Sulfatase* / genetics
  • Iduronic Acid
  • Induced Pluripotent Stem Cells* / pathology
  • Mucopolysaccharidosis II* / genetics
  • Mucopolysaccharidosis II* / pathology
  • Phenotype

Substances

  • Glycosaminoglycans
  • Iduronic Acid
  • Iduronate Sulfatase